Revolution Medicines Stock Price on April 11, 2024
| RVMD Stock | USD 44.06 0.77 1.78% |
Below is the normalized historical share price chart for Revolution Medicines extending back to February 13, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Revolution Medicines stands at 44.06, as last reported on the 21st of December, with the highest price reaching 44.22 and the lowest price hitting 42.53 during the day.
If you're considering investing in Revolution Stock, it is important to understand the factors that can impact its price. At this point, Revolution Medicines is very steady. Revolution Medicines maintains Sharpe Ratio (i.e., Efficiency) of 0.0323, which implies the firm had a 0.0323% return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Revolution Medicines, which you can use to evaluate the volatility of the company. Please check Revolution Medicines' Risk Adjusted Performance of (0.0004), coefficient of variation of (10,333), and Variance of 8.57 to confirm if the risk estimate we provide is consistent with the expected return of 0.0925%.
At present, Revolution Medicines' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 3.1 B, whereas Common Stock is forecasted to decline to 8,067. . At present, Revolution Medicines' Price Sales Ratio is projected to increase significantly based on the last few years of reporting. Revolution Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 13th of February 2020 | 200 Day MA 42.7898 | 50 Day MA 51.921 | Beta 1.404 |
Revolution |
Sharpe Ratio = 0.0323
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | RVMD | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.86 actual daily | 25 75% of assets are more volatile |
Expected Return
| 0.09 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Revolution Medicines is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Revolution Medicines by adding it to a well-diversified portfolio.
Price Book 5.065 | Enterprise Value Ebitda (9.71) | Price Sales 10.8 K | Shares Float 154.8 M | Wall Street Target Price 73 |
Related Headline
Avidity Biosciences Headline on 11th of April 2024
Acquisition by Kaye Edward M. Md of 22000 shares of Avidity ... by Kaye Edward M. Md
Filed transaction by Avidity BiosciencesInc Director. Grant, award or other acquisition pursuant to Rule 16b-3
Revolution Medicines Valuation on April 11, 2024
It is possible to determine the worth of Revolution Medicines on a given historical date. On April 11, 2024 Revolution was worth 36.69 at the beginning of the trading date compared to the closed value of 37.41. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Revolution Medicines stock. Still, in general, we apply an absolute valuation method to find Revolution Medicines' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Revolution Medicines where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Revolution Medicines' related companies.
| Open | High | Low | Close | Volume | |
| 33.98 | 37.50 | 33.62 | 36.50 | 4,427,399 | |
04/11/2024 | 36.69 | 38.73 | 35.60 | 37.41 | 2,506,456 |
| 37.79 | 37.98 | 35.21 | 36.07 | 1,634,589 |
| Backtest Revolution Medicines | | | Revolution Medicines History | | | Revolution Medicines Valuation | Previous | Next |
Revolution Medicines Trading Date Momentum on April 11, 2024
| On April 12 2024 Revolution Medicines was traded for 36.07 at the closing time. The top price for the day was 37.98 and the lowest listed price was 35.21 . The trading volume for the day was 1.6 M. The trading history from April 12, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 3.58% . The trading delta at closing time against the current closing price is 5.61% . |
Revolution Medicines Fundamentals Correlations and Trends
By evaluating Revolution Medicines' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Revolution Medicines' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Revolution financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Revolution Medicines Stock history
Revolution Medicines investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Revolution is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Revolution Medicines will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Revolution Medicines stock prices may prove useful in developing a viable investing in Revolution Medicines
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 113.1 M | 73.1 M | |
| Net Loss | -223.8 M | -212.6 M |
Revolution Medicines Quarterly Net Working Capital |
|
Revolution Medicines Stock Technical Analysis
Revolution Medicines technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Revolution Medicines Period Price Range
Low | December 21, 2024
| High |
0.00 | 0.00 |
Revolution Medicines cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Revolution Medicines December 21, 2024 Market Strength
Market strength indicators help investors to evaluate how Revolution Medicines stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Revolution Medicines shares will generate the highest return on investment. By undertsting and applying Revolution Medicines stock market strength indicators, traders can identify Revolution Medicines entry and exit signals to maximize returns
Revolution Medicines Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Revolution Medicines' price direction in advance. Along with the technical and fundamental analysis of Revolution Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Revolution to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.0004) | |||
| Jensen Alpha | (0.07) | |||
| Total Risk Alpha | (0.12) | |||
| Treynor Ratio | (0.03) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Revolution Stock analysis
When running Revolution Medicines' price analysis, check to measure Revolution Medicines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines is operating at the current time. Most of Revolution Medicines' value examination focuses on studying past and present price action to predict the probability of Revolution Medicines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines' price. Additionally, you may evaluate how the addition of Revolution Medicines to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |